Aegerion Pharmaceuticals, Inc. Observes Familial Hypercholesterolemia Awareness Day
Published: Sep 24, 2013
CAMBRIDGE, Mass., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today its alliance with The FH Foundation in observance of the annual Familial Hypercholesterolemia (FH) Awareness Day.
Help employers find you! Check out all the jobs and post your resume.